BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
BIO-RAD LABORATORIES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$352.82−0.88 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $9.46B
- P/E (TTM)
- 42.8
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
22M of 22M shares
Institutional holders
398
61 new, 51 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $349.88K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Norman D. Schwartz | 3,228,922 | 14.60% | 13D (active) amendment | Sep 25, 2025 |
| Alice N. Schwartz | 2,732,073 | 12.30% | 13D (active) amendment | May 1, 2025 |
| First Eagle Investment Management, LLC | 2,528,321 | 11.40% | 13G (passive) amendment | Jun 30, 2025 |
| The Vanguard Group - 23-1945930 | 1,907,640 | 8.37% | 13G (passive) amendment | Sep 30, 2024 |
| BlackRock, Inc. | 1,618,123 | 7.40% | 13G (passive) amendment | Sep 30, 2025 |
| Van Eck Associates Corporation 666 Third Ave. - 9th Floor, New York, New York 10017 | 1,306,473 | 5.73% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BIO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| First Eagle Investment Management, LLC | 5,212,438 | 24.05% | $1.53B | +2,609,666 | 1.27% |
| BlackRock, Inc. | 1,698,929 | 7.84% | $498.82M | +18,869 | 0.01% |
| Dimensional Fund Advisors LP | 944,548 | 4.36% | $277.33M | −144,775 | 0.05% |
| Vanguard Capital Management LLC | 826,972 | 3.81% | $242.81M | −4,193 | 0.01% |
| Ariel Investments, LLC | 816,751 | 3.77% | $239.81M | +30,790 | 2.39% |
| Vanguard Portfolio Management LLC | 816,198 | 3.77% | $239.64M | −12,988 | 0.01% |
| Earnest Partners LLC | 580,752 | 2.68% | $170.51M | −7,979 | 0.61% |
| State Street Corp | 571,762 | 2.64% | $167.88M | +12,192 | 0.00% |
| Bank Of America Corp /De/ | 490,412 | 2.26% | $143.99M | +45,455 | 0.01% |
| Assenagon Asset Management S.A. | 466,454 | 2.15% | $136.96M | +318,620 | 0.09% |
| Capital World Investors | 462,457 | 2.13% | $135.78M | +12,457 | 0.02% |
| Capital Research Global Investors | 443,483 | 2.05% | $130.21M | +57,904 | 0.02% |
| UBS Asset Management Americas Inc | 418,884 | 1.93% | $122.99M | −7,154 | 0.02% |
| First Pacific Advisors, LP | 401,861 | 1.85% | $117.99M | −5,497 | 1.46% |
| Geode Capital Management, LLC | 347,575 | 1.60% | $102.08M | −17,107 | 0.01% |
| Nomura Holdings Inc | 328,897 | 1.52% | $96.57M | +111,555 | 0.11% |
| UBS Group AG | 308,325 | 1.42% | $90.53M | −46,040 | 0.01% |
| Sei Investments Co | 273,377 | 1.26% | $80.26M | −14,535 | 0.07% |
| Barclays PLC | 267,634 | 1.23% | $78.58M | −11,201 | 0.02% |
| Deerfield Management Company, L.P. (Series C) | 226,070 | 1.04% | $66.38M | – | 0.69% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 398 | 22M | 100.0% | 61 / 114 | 154 / 51 | 5M | 2M |
| Q1 2026 | 394 | 20M | 92.2% | 62 / 144 | 99 / 61 | 5M | 3M |
| Q4 2025 | 399 | 20M | 91.1% | 59 / 106 | 148 / 51 | 2M | 2M |
| Q3 2025 | 397 | 20M | 90.2% | 64 / 120 | 140 / 47 | 2M | 2M |
| Q2 2025 | 384 | 19M | 89.2% | 53 / 114 | 169 / 100 | 3M | 3M |
| Q1 2025 | 435 | 19M | 89.9% | 68 / 136 | 165 / 83 | 3M | 2M |
| Q4 2024 | 457 | 19M | 86.7% | 81 / 148 | 147 / 56 | 1M | 2M |
| Q3 2024 | 439 | 19M | 89.9% | 70 / 132 | 170 / 68 | 5M | 4M |
| Q2 2024 | 440 | 20M | 91.7% | 60 / 135 | 180 / 80 | 3M | 2M |
| Q1 2024 | 465 | 19M | 88.1% | 54 / 170 | 165 / 70 | 3M | 2M |
| Q4 2023 | 484 | 19M | 86.9% | 87 / 164 | 172 / 64 | 3M | 3M |
| Q3 2023 | 468 | 19M | 86.7% | 59 / 146 | 181 / 58 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BIO | Value | % of fund | As of |
|---|---|---|---|---|---|
| First Eagle Global Fund | 1,878,739 | 8.67% | $611.49M | 0.80% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 881,719 | 4.07% | $258.88M | 0.27% | Jun 30, 2026 |
| iShares Core S&P Mid-Cap ETF | 616,693 | 2.84% | $181.07M | 0.15% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 584,782 | 2.70% | $171.70M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 423,193 | 1.95% | $124.25M | 0.07% | Jun 30, 2026 |
| Ariel Fund | 349,270 | 1.61% | $102.55M | 3.54% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 291,328 | 1.34% | $94.82M | 0.49% | Jul 31, 2026 |
| MFS Mid Cap Growth Fund | 276,995 | 1.28% | $86.56M | 0.63% | May 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 267,971 | 1.24% | $78.68M | 0.12% | Jun 30, 2026 |
| FPA Crescent Fund | 244,376 | 1.13% | $71.75M | 0.58% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 206,734 | 0.95% | $60.70M | 0.06% | Jun 30, 2026 |
| Fidelity Value Fund | 130,200 | 0.60% | $42.38M | 0.40% | Jul 31, 2026 |
| Dimensional US Small Cap Value ETF | 119,060 | 0.55% | $38.75M | 0.47% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 93,657 | 0.43% | $29.27M | 0.07% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 91,182 | 0.42% | $26.77M | 0.15% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Norman D. Schwartz | Chairman & CEO, Director, 10% owner | 7,696,966 | 35.51% | Sep 9, 2026 |
| Jonathan P. DiVincenzo | President & COO | 2,631 | 0.01% | Sep 9, 2026 |
| Roop Kalyan Lakkaraju | EVP, Chief Financial Officer | 4,151 | 0.02% | Sep 9, 2026 |
| Sedat Evran | EVP, Global Supply Chain | 3,880 | 0.02% | Sep 9, 2026 |
| James Barry | EVP, President, LSG | 2,025 | 0.01% | Sep 9, 2026 |
| Eva Anette Engelhardt | EVP, President, CDG | 1,828 | 0.01% | Sep 9, 2026 |
| Courtney C. Enloe | EVP, General Counsel & Sec | 1,652 | 0.01% | Sep 9, 2026 |
| Rajat Mehta | EVP, GBL Commercial Operations | 1,232 | 0.01% | Sep 9, 2026 |
| Colleen Corey | EVP, Global Human Resources | 19,550 | 0.09% | Sep 9, 2025 |
| Michael Crowley | EVP, GBL Commercial Operations | 8,171 | 0.04% | Mar 18, 2025 |
| Schwartz Allison | Director | 1,768 | 0.01% | Sep 9, 2026 |
| Melinda Litherland Pei | Director | 715 | 0.00% | Apr 23, 2026 |
| Jeffrey L. Edwards | Director | 715 | 0.00% | Apr 23, 2026 |
| Greg K. Hinckley | Director | 1,215 | 0.01% | Apr 23, 2026 |
| Arnold A. Pinkston | Director | 715 | 0.00% | Apr 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Courtney C. Enloe EVP, General Counsel & Sec | Sep 6, 2026 | Tax withholding | −305 | $386.11 | $117.76K | 1,652 |
| Courtney C. Enloe EVP, General Counsel & Sec | Sep 6, 2026 | Option exercise | +768 | – | – | 1,957 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 6, 2026 | Tax withholding | −485 | $386.11 | $187.26K | 1,828 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 6, 2026 | Option exercise | +1,152 | – | – | 2,313 |
| Schwartz Allison Director | Sep 6, 2026 | Option exercise | +92 | – | – | 1,768 |
| Schwartz Allison Director | Sep 6, 2026 | Tax withholding | −34 | $386.11 | $13.13K | 1,734 |
| James Barry EVP, President, LSG | Sep 6, 2026 | Tax withholding | −470 | $386.11 | $181.47K | 2,025 |
| James Barry EVP, President, LSG | Sep 6, 2026 | Option exercise | +1,056 | – | – | 2,495 |
| Sedat Evran EVP, Global Supply Chain | Sep 6, 2026 | Option exercise | +864 | – | – | 3,880 |
| Sedat Evran EVP, Global Supply Chain | Sep 6, 2026 | Tax withholding | −277 | $386.11 | $106.95K | 3,603 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Sep 6, 2026 | Tax withholding | −782 | $386.11 | $301.94K | 4,151 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Sep 6, 2026 | Option exercise | +1,536 | – | – | 4,933 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 6, 2026 | Tax withholding | −1,854 | $386.11 | $715.85K | 449,019 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 6, 2026 | Option exercise | +3,455 | – | – | 450,873 |
| Rajat Mehta EVP, GBL Commercial Operations | Sep 5, 2026 | Tax withholding | −504 | $386.11 | $194.60K | 1,232 |
| Rajat Mehta EVP, GBL Commercial Operations | Sep 5, 2026 | Option exercise | +1,370 | – | – | 1,736 |
| Rajat Mehta EVP, GBL Commercial Operations | Sep 5, 2026 | Tax withholding | −233 | $386.11 | $89.96K | 366 |
| Rajat Mehta EVP, GBL Commercial Operations | Sep 5, 2026 | Option exercise | +456 | – | – | 599 |
| Courtney C. Enloe EVP, General Counsel & Sec | Sep 5, 2026 | Tax withholding | −246 | $386.11 | $94.98K | 1,189 |
| Courtney C. Enloe EVP, General Counsel & Sec | Sep 5, 2026 | Option exercise | +685 | – | – | 1,435 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 5, 2026 | Tax withholding | −369 | $386.11 | $142.47K | 1,161 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 5, 2026 | Option exercise | +1,027 | – | – | 1,530 |
| Schwartz Allison Director | Sep 5, 2026 | Tax withholding | −82 | $386.11 | $31.66K | 1,676 |
| Schwartz Allison Director | Sep 5, 2026 | Option exercise | +228 | – | – | 1,758 |
| James Barry EVP, President, LSG | Sep 5, 2026 | Option exercise | +1,027 | – | – | 1,808 |
| James Barry EVP, President, LSG | Sep 5, 2026 | Tax withholding | −369 | $386.11 | $142.47K | 1,439 |
| Sedat Evran EVP, Global Supply Chain | Sep 5, 2026 | Option exercise | +1,027 | – | – | 3,345 |
| Sedat Evran EVP, Global Supply Chain | Sep 5, 2026 | Tax withholding | −329 | $386.11 | $127.03K | 3,016 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Sep 5, 2026 | Option exercise | +1,370 | – | – | 3,956 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Sep 5, 2026 | Tax withholding | −559 | $386.11 | $215.84K | 3,397 |
| Jonathan P. DiVincenzo President & COO | Sep 5, 2026 | Option exercise | +1,712 | – | – | 2,631 |
| Jonathan P. DiVincenzo President & COO | Sep 5, 2026 | Tax withholding | −668 | $386.11 | $257.92K | 1,963 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 5, 2026 | Option exercise | +4,109 | – | – | 450,294 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 5, 2026 | Tax withholding | −2,876 | $386.11 | $1.11M | 447,418 |
| James Barry EVP, President, LSG | Sep 1, 2026 | Tax withholding | −154 | $380.96 | $58.67K | 781 |
| James Barry EVP, President, LSG | Sep 1, 2026 | Option exercise | +425 | – | – | 935 |
| Schwartz Allison Director | Sep 1, 2026 | Option exercise | +117 | – | – | 1,573 |
| Schwartz Allison Director | Sep 1, 2026 | Tax withholding | −43 | $380.96 | $16.38K | 1,530 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 1, 2026 | Tax withholding | −2,336 | $380.96 | $889.92K | 446,185 |
| Norman D. Schwartz Chairman & CEO, Director, 10% owner | Sep 1, 2026 | Option exercise | +5,087 | – | – | 448,521 |
| Eva Anette Engelhardt EVP, President, CDG | Jul 25, 2026 | Option exercise | +246 | – | – | 592 |
| Eva Anette Engelhardt EVP, President, CDG | Jul 25, 2026 | Tax withholding | −89 | $314.46 | $27.99K | 503 |
| Eva Anette Engelhardt EVP, President, CDG | May 11, 2026 | Sale | −550 | $246.54 | $135.60K | 346 |
| Courtney C. Enloe EVP, General Counsel & Sec | Apr 24, 2026 | Tax withholding | −77 | $287.84 | $22.16K | 750 |
| Courtney C. Enloe EVP, General Counsel & Sec | Apr 24, 2026 | Option exercise | +186 | – | – | 827 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Apr 24, 2026 | Tax withholding | −420 | $287.84 | $120.89K | 2,564 |
| Roop Kalyan Lakkaraju EVP, Chief Financial Officer | Apr 24, 2026 | Option exercise | +1,078 | – | – | 2,984 |
| Melinda Litherland Pei Director | Apr 21, 2026 | Option exercise | +407 | – | – | 715 |
| Jeffrey L. Edwards Director | Apr 21, 2026 | Option exercise | +407 | – | – | 715 |
| Greg K. Hinckley Director | Apr 21, 2026 | Option exercise | +407 | – | – | 1,215 |
| Arnold A. Pinkston Director | Apr 21, 2026 | Option exercise | +407 | – | – | 715 |
| James Barry EVP, President, LSG | Nov 6, 2025 | Sale | −699.87 | $306.18 | $214.29K | 510 |
| Jonathan P. DiVincenzo President & COO | Oct 24, 2025 | Option exercise | +1,869 | – | – | 1,869 |
| Jonathan P. DiVincenzo President & COO | Oct 24, 2025 | Tax withholding | −950 | $339.75 | $322.76K | 919 |
| Sedat Evran EVP, Global Supply Chain | Oct 20, 2025 | Option exercise | +1,044 | – | – | 2,568 |
| Sedat Evran EVP, Global Supply Chain | Oct 20, 2025 | Tax withholding | −335 | $321.90 | $107.84K | 2,233 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 6, 2025 | Option exercise | +1,152 | – | – | 1,309 |
| Eva Anette Engelhardt EVP, President, CDG | Sep 6, 2025 | Tax withholding | −413 | $295.43 | $122.01K | 896 |
| Colleen Corey EVP, Global Human Resources | Sep 6, 2025 | Tax withholding | −209 | $295.43 | $61.74K | 19,550 |
| Colleen Corey EVP, Global Human Resources | Sep 6, 2025 | Option exercise | +576 | – | – | 19,759 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Institute for Medical Research Corp Alles Director, 10% Stockholder | May 28, 2026 | 700 | $219.30K | May 28, 2026 | Donation |
| Engelhardt Eva Officer | May 11, 2026 | 550 | $135.60K | May 11, 2026 | Restricted Stock |
| W. Crowley Michael Officer | Dec 2, 2025 | 776 | $247.98K | Dec 2, 2025 | Restricted Stock |
| Institute for Medical Research Corp Alles Director, 10% Stockholder | Nov 18, 2025 | 760 | $228.79K | Nov 18, 2025 | Donation |
| Barry James Officer | Nov 6, 2025 | 701 | $214.63K | Nov 6, 2025 | Restricted Stock |
| W. Crowley Michael Officer | Aug 5, 2025 | 1,488 | $410.57K | Aug 5, 2025 | Restricted Stock |
| Michael Crowley Officer | Mar 13, 2025 | 3,000 | $780.00K | Mar 13, 2025 | STOCK OPTION EXERCISE |
| Institute for Medical Research Corp Alles Director, 10% Stockholder | Mar 11, 2025 | 410 | $101.54K | Mar 11, 2025 | Donation |
| Andrew J. Last Officer | Nov 6, 2024 | 3,000 | $1.12M | Nov 6, 2024 | RESTRICTED STOCK |
| Andrew J. Last Officer | Sep 12, 2024 | 1,600 | $514.50K | Sep 12, 2024 | RESTRICTED STOCK |
| Andrew J. Last Officer | Sep 6, 2024 | 3,000 | $989.82K | Sep 6, 2024 | STOCK OPTION EXERCISE |
| James Barry Officer | Sep 4, 2024 | 623 | $205.90K | Sep 4, 2024 | RESTRICTED STOCK |
| Institute for Medical Research Corp Alles Director, 10% Stockholder | Aug 27, 2024 | 990 | $308.22K | Aug 27, 2024 | Donation |
| Michael Crowley Officer | Jun 13, 2024 | 369 | $104.02K | Jun 13, 2024 | RESTRICTED STOCK |
| Timothy S. Ernst Officer | Feb 28, 2024 | 2,500 | $826.36K | Feb 28, 2024 | STOCK OPTION EXERCISE |